1. Introduction {#sec1}
===============

In A Dictionary of Epidemiology, representativeness is defined as "The degree to which the characteristics of a study (notably, of study subjects and setting, but sometimes also of exposures and outcomes) are similar to those of an external population that did not participate in the study. Representativeness is time-, place-, and context-specific" ([@bib65], p. 247). In particular descriptive studies that typically aim to estimate disease burden need to be representative of the target population ([@bib65], p. 247; [@bib68]).

Current guidelines state that social and demographic characteristics should be used to describe a study population in addition to health-related indicators ([@bib34]; [@bib76]). The National Institutes of Health (NIH) issued a policy that obliges investigators of NIH-funded clinical research to report the composition of the study population with regard to sex and ethnic or racial minority groups ([@bib54]). Reviews of studies on substance abuse and physical therapy reported that age and sex are regularly used to describe the study population, while all other social or demographic characteristics are used irregularly ([@bib12]; [@bib25]).

To describe representativeness, characteristics of the study population can be compared to the target population using data of the sampling frame, of non-responder-surveys or of censuses ([@bib7]; [@bib32]). In addition, response proportions can be calculated ([@bib71]), however, high response proportions do not necessarily indicate representativeness, because extended recruitment efforts might increase the relative share of population groups that are most likely to participate ([@bib7]). On the other hand, the magnitude of bias of an estimate of disease frequency might be lower in studies with high response proportions ([@bib39]).

It has been argued that a sample can be called representative if a sampling technique such as probability sampling has been used ([@bib42]; [@bib43]; [@bib44]). However, despite probability sampling leading to a higher chance of creating a representative sample, study participation is highly likely to distort representativeness ([@bib6]). Therefore, further investigations of representativeness are needed after recruitment has been completed ([@bib7]).

If representativeness is understood as a portrayal of a society, we would argue that these investigations should be informed by sociological theory as for example understood by Krieger ([@bib41]). Merely stringing together some social or demographic characteristics does not allow an informed analysis of representativeness for complex societies. As a first step to overcome this limitation, we propose to apply an intersectional framework. Intersectionality considers the multiplicity of social location, meaning different intersects of positions individuals act from and are acted on in society ([@bib1]; [@bib26]). Such a framework may be well suited to expand the notion of representativeness of a sample to include a theory-based understanding of the underlying society.

Crenshaw coined the term intersectionality when she illustrated that lived experiences of black women are incomparable to both white females and black males. She supported her argument using case studies of legal discrimination against black women in the US ([@bib15]). Taking account of situated experiences of multiple discrimination, intercategorical intersectionality posits that characteristics of social location such as race or sex/gender cannot be investigated separately but that combinations of these characteristics need to be the basis of analysis ([@bib5]; [@bib10]; [@bib16]; [@bib48]). Intersectionality theory highlights that axes of power relations, which create privileged and oppressed social locations, are interlocking and mutually constituting ([@bib80]).

As a corollary, characteristics that are meaningful in an intersectional approach are characteristics related to social differentiation or power ([@bib26]). The PROGRESS plus framework provides an overview of social groupings for whom anti-discrimination legislation had been enacted in the US ([@bib19]; [@bib58]). Within the framework, 11 groupings have been defined, namely place of residence, ethnicity, occupation, gender, religion, education, socioeconomic status (SES), social capital, disability, age, and sexuality without claiming completeness ([@bib58]). SES does not refer to a multidimensional construct of income, occupation and education but to material circumstances ([@bib58]). In this paper, we use sex/gender to express that the embodiment of gender complicates a clear separation of the biological concept of sex and the social concept of gender ([@bib40]). Furthermore, we use dis/ability to avoid language that conveys disablism. Finally, it has been suggested that PROGRESS plus might be used to select meaningful social characteristics to describe a study population ([@bib19]; [@bib57]; [@bib58]). Characteristics that have shown to be associated with study participation are place of residence, ethnicity, social class, sex, education, income, marital status and age ([@bib6]; [@bib14]; [@bib55]; [@bib69]; [@bib77]).

To contextualize our theoretical argument, we investigated the practice of reporting social characteristics when describing representativeness at baseline of selected epidemiological cohort studies in a narrative review. We asked if and how study and target population were compared, and which social characteristics of the study population were reported. Finally, we aimed to report results of comparisons of the study populatiom with the target population after stratifying the populations by two or more social characteristics. These strata can be called intersectional strata, because they reveal combinations of social characteristics ([@bib20]). By doing so, we intended to explore whether a description of representativeness applying an intersectional perspective might yield results that would have been masked when assuming independence of social characteristics.

2. Methods {#sec2}
==========

2.1. Search strategy {#sec2.1}
--------------------

This study was part of the project AdvanceGender ([@bib64]). We conducted a narrative review of published information about representativeness at baseline of a priori selected epidemiological cohort studies. In a first step, epidemiological cohort studies were included according to two criteria: Studies needed to include a general adult population and baseline recruitment needed to be complete before 2019. In order to analyze descriptions of representativeness of cohort studies, we chose a subjective selection process of individual studies. We considered three sources to search for eligible studies. First, studies that were well-known to the authors were selected. Subsequently, Google and Google Scholar were searched with the terms "cohort study", "cohort profile", and "health" to identify further cohort studies. Finally, websites and methodological publications of already included studies were screened for cross references to other cohort studies. Once identified, the name of the included study, country, number of participants, time of recruitment, and age and sex/gender of participants were recorded.

In the second step, we collected information on the study methodology of each cohort. Therefore, we searched for any kind of methodological publication about representativeness of the identified studies. More precisely, we aimed to include descriptions about study design, study population, study participation, recruitment, response, representativeness or any method of comparison of the study population to the target population. Publications about the baseline population of the cohort studies were included, while publications on attrition or retention during follow-up were excluded. Moreover, any publication that addressed a specific research question was excluded. Only publications in English or German were considered.

To get the information on study methodology we first searched the content of study-websites. Furthermore, we searched publication lists of the study-websites for peer-reviewed publications and grey literature on methodology. Medline, Google, and Google Scholar were additionally searched using the name and acronym of the study and the keywords "cohort profile", "study design", "study description", "study population", "participation", "recruitment", "response" and "representativeness". If none or little information about representativeness at baseline was found, we additionally searched reference lists of publications of the respective cohort studies for cross references to methodological publications. If two or more publications were found, we included the publication which contained most information. If the reported information concerning one cohort was not congruent, we included all identified sources of information.

2.2. Data extraction {#sec2.2}
--------------------

Information on the method of describing representativeness of the study population after recruitment was extracted from the identified websites and publications. Four categories of methods were considered. First, we recorded whether any summary statistic of social characteristics of the study population was presented (A). Reporting response proportions according to Slattery et al. and stratifying them according to age or sex/gender was considered the second method (B) ([@bib71]). Third, methods using non-responder surveys to compare characteristics of responders to non-responders (C) and, fourth, methods comparing characteristics other than age and sex/gender of the study population to the target population using the sampling frame, census data or data of representative external studies (D) were extracted.

Moreover, any reported social characteristic used to describe the study population was extracted from the identified publications and documented in a spreadsheet. The characteristics as reported in the publications were allocated to one PROGRESS plus group. We compiled a summary for each study indicating PROGRESS plus groups for which at least one characteristic of the study population was reported. We highlighted groups in which one characteristic was stratified by one or more characteristics of another PROGRESS plus group.

Strata of combinations of two or more social characteristics can be called intersectional strata ([@bib20]). Comparisons of intersectional strata of the study population to the target population were summarized and reported following the scheme of PROGRESS plus. An assessment of risk of bias of individual studies was not performed. We address the possibility of publication bias in the Discussion.

3. Restults {#sec3}
===========

3.1. Included studies and publications {#sec3.1}
--------------------------------------

We included 24 epidemiological cohort studies. All included studies ordered chronologically according to their baseline recruitment are displayed in [Table 1](#tbl1){ref-type="table"}. The study sizes ranged from 4261 to 519978 participants. The earliest included study started recruiting in 1948. Two studies were restricted to females. 29 publications were identified, among them 26 journal articles and 3 reports from study homepages that met the inclusion criteria ([Table 2](#tbl2){ref-type="table"}).Table 1Characteristics of included cohort studies.Table 1Study nameAcronymStudy designCountryRestriction to sex/genderTarget age range at baselineTime of recruitmentParticipants at baselineFramingham Heart StudyFHScohort studyUnited States of America30--59 years19485209The National FINRISK Study (1972--1992 surveys)FINRISK 72-92cohort studyFinland25--74 years1972--199245902The Nurses Health Study INHS Ioccupational cohort studyUnited States of Americarestriction to females30--55 years1976121700The Whitehall II StudyWhitehall IIoccupational cohort studyUnited Kingdom35--55 years1985--198810314GAZ and Electricité StudyGAZELoccupational cohort studyFrancefemales: 35--50 years\
males: 40--50 years198920625The Avon Longitudinal Study of Parents and Children (mothers cohort)ALSPAC mothersbirth cohort studyUnited Kingdomrestriction to femalesno age range1991--199213761European Prospective Investigation into Cancer and Nutrition (international)EPICcohort study10 European countries35--701992--2000519978Västerbotten Intervention Programme (surveys of the years 1992 and 1993)VIP 92/93cohort studySweden20--60 years1992--199314188Monitoring Project on Risk Factors for Chronic DiseasesMORGENcohort studyThe Netherlands20--59 years1993--199722769European Prospective Investigation into Cancer and Nutrition (Germany)EPIC Germanycohort studyGermanywomen: 35--64 years\
men: 40--64 years1994--199853162Cohort of NorwayCONORcohort studyNorwayolder than 20 years1994--2003173236The National Longitudinal Study of Adolescent to Adult HealthAdd Healthcohort studyUnited States of Americaadolescents in high school1994--199590000Study of Health in PomeraniaSHIPcohort studyGermany20--791997--20014308Cooperative Health Research in the Region Augsburg (survey of the year 2000)KORA 2000cohort studyGermany25--74 years20004261Multi-Ethnic Study of AtherosclerosisMESAcohort studyUnited States of America45--84 years2000--20026814Heinz Nixdorf Recall StudyHNRcohort studyGermany45--75 years2000--20034487Health, Alcohol and Psychosocial factors in Eastern EuropeHAPIEEcohort studyCzech Republic, Poland, Russia45--69 years2002--200536500China Kadoorie BiobankCKBcohort studyChina35--74 years2004--2008515681UK BiobankUK Biobankcohort studyUnited Kingdom40--69 years2006--2010500000LifeLines StudyLifeLinescohort studyThe Netherlandsolder than 6 months2006--2013167729Tromsø 6Tromsø 6cohort studyNorway30--87 years2007--200812984CARTaGENE StudyCaGcohort studyCanada40--69 years2009--201420007Leben in der ArbeitLidAoccupational cohort studyGermanyborn in 1959 or 196520116585CONSTANCES StudyCONSTANCESoccupational cohort studyFrance18--69 years2012--201720000Table 2Included publications and method of describing representativeness of the study population.Table 2StudyIncluded publicationsMethod of describing representativeness of the study populationResponse proportionABCDFHS[@bib24]XXX69%FINRISK\
72--92([@bib9]; [@bib27])XXX85%NHS I[@bib4]XX71%Whitehall II[@bib47]XX73%GAZEL[@bib23]XXX45%ALSPAC mothers[@bib21]XXX75%[b](#tbl2fnb){ref-type="table-fn"}EPIC[@bib67]Xnot reportedVIP 92/93[@bib79]XXX57%MORGEN[@bib75]XXXX45%EPIC Germany[@bib8]XXX28%CONOR[@bib53]Xnot reportedAdd Health([@bib28]; [@bib36])X79%[c](#tbl2fnc){ref-type="table-fn"}SHIP([@bib46]; [@bib78])XXX69%[a](#tbl2fna){ref-type="table-fn"}KORA 2000([@bib33]; [@bib66])XXX65%MESA[@bib59]Xnot reportedHNR[@bib73]XXX53%HAPIEE[@bib61]XX59%CKB[@bib11]Xnot reportedUK Biobank[@bib22]XXX6%LifeLines[@bib38]XXnot reportedTromsø 6[@bib17]XXX66%CaG[@bib2]XXX26%[a](#tbl2fna){ref-type="table-fn"}LidA[@bib29]XXX27%CONSTANCES([@bib81]; [@bib82])XXnot reported[^1][^2][^3][^4]

3.2. Method of describing representativeness of the study population {#sec3.2}
--------------------------------------------------------------------

In the identified publications of four cohort studies we could find neither information on response proportions nor any comparison to the target population ([Table 2](#tbl2){ref-type="table"}). Four cohort studies exclusively reported aggregated response proportions or response proportions stratified by sex/gender or age. Six cohort studies reported results of a comparison of study participants to participants of a non-responder survey. In eleven studies, comparisons of characteristics of the study population other than age or sex/gender to the target population were conducted using data of the sampling frame, representative censuses or representative survey data. Response proportions ranged from 6% to 84%.

3.3. Reported social characteristics of the study population and allocation to PROGRESS plus groups {#sec3.3}
---------------------------------------------------------------------------------------------------

The allocation of reported social characteristics to PROGRESS plus groups is summarized in [Table 3](#tbl3){ref-type="table"}. All reported characteristics could be allocated to a PROGRESS plus group. The groups "place of residence", "ethnicity", "occupation", "socioeconomic status", and "social capital" included heterogeneous characteristics.Table 3Allocation of reported social characteristics to PROGRESS plus groups.Table 3PROGRESS plus groupReported social characteristicsPlace of residencepolitical regionsgeographical regionspopulation size of the regionpopulation density of the regiondistance to study centerregional deprivationEthnicityethnicityracelanguagemigration backgroundnationalityplace of birthOccupationeconomic sector of occupationtype of occupationunemploymentmarginal employmentpart time employmentemployment gradeduration of employmentSex/genderbinary sex/genderReligion--Educationeducational levelduration of educationSocioeconomic statusincomeproperty ownershipcar ownershipnumber of persons living in a roomtype of housingSocial capitalrelationship statuscohabitationmarital statusnumber of childrenAgeage-groupsmean agebirth cohortDis/ability--Sexuality--

[Fig. 1](#fig1){ref-type="fig"} shows PROGRESS plus groups for which at least one characteristic has been used to describe the study population and whether these variables had been stratified by variables of other groups. "Sex/gender", "age" and "place of residence" were reported most frequently. No study reported characteristics of the groups "religion", "dis/ability" and "sexuality". If stratification was applied, characteristics were most often stratified by "sex/gender" followed by "age".Fig. 1Summary of PROGRESS plus groups used to describe the study population and their mutual stratification in the included cohort studies.Fig. 1

3.4. Comparisons of intersectional strata of the study population to the target population {#sec3.4}
------------------------------------------------------------------------------------------

### 3.4.1. Place {#sec3.4.1}

Ranges of response rates within the districts of Framingham were similar among women and men in the FHS ([@bib24]). In the NHS I, overall response proportions in states of the US were similar to response proportions after stratification by age ([@bib4]). EPIC Germany reported a larger female to male ratio of response proportions in Potsdam (city in former East Germany) compared to Heidelberg (city in former West Germany) ([@bib8]). KORA reported a slightly higher response to a non-responder survey among females in rural areas compared to females in urban areas ([@bib33]). LidA reported that the study population of two birth cohorts was representative for the population in former East and West Germany ([@bib29]).

### 3.4.2. Ethnicity {#sec3.4.2}

The LidA study stratified nationality by birth cohort and reported a higher representation of foreign nationals in the younger cohort ([@bib29]).

### 3.4.3. Occupation {#sec3.4.3}

In the NHS I, overall response proportions of the variables field of employment and unemployment status were similar to response proportions after stratification by age ([@bib4]). FINRISK found that manual workers were underrepresented among women and men ([@bib27]). In GAZEL, employment grade was stratified by sex/gender. Response proportions were approximately double among both female and male managers compared to unskilled workers ([@bib23]). Furthermore, time in employment was stratified by sex/gender and employment grade. Only female managers were more likely to participate with increasing length of employment ([@bib23]). Conversely, odds of participation decreased only among male unskilled workers with time of employment ([@bib23]). In EPIC Germany, the proportion of female blue-collar workers was a quarter compared to the target population, while the proportion of male blue-collar workers was half ([@bib8]). LidA compared proportions of occupational groups, people in part-time employment and people in marginal work in both birth cohorts to the target population and found no differences ([@bib29]).

### 3.4.4. Sex/gender {#sec3.4.4}

Stratification by sex/gender has been described in paragraphs about other PROGRESS plus groups.

### 3.4.5. Religion {#sec3.4.5}

Characteristics related to religion were not reported in any study.

### 3.4.6. Education {#sec3.4.6}

Among nurses in the NHS I, overall response proportions according to educational level did not differ from response proportions after stratification by age ([@bib4]). FINRISK reported no differences between study population and target population according to level of education among both women and men ([@bib27]). In GAZEL, education was associated with response among female but not male managers ([@bib23]). Among unskilled workers, higher education was associated with higher response among men, but not women ([@bib23]). In EPIC Germany and HNR, underrepresentation of people with low educational levels did not differ by sex/gender ([@bib8]; [@bib73]). LidA reported no differences between study population and target population after stratifying educational levels by birth cohort ([@bib29]).

### 3.4.7. SES {#sec3.4.7}

Both women and men with a low income were underrepresented in FINRISK ([@bib27]). GAZEL reported that the odds of participation were higher among both males and females living in employer-provided housing compared to those living in private housing ([@bib23]). In LidA, income groups stratified by birth cohort were representative of the target population ([@bib29]).

### 3.4.8. Social capital {#sec3.4.8}

In GAZEL, number of children interacted with sex/gender and employment grade. Only unskilled and skilled male workers were more likely to participate when having more children, while having more children was not associated with participation among male managers or females ([@bib23]). In the HNR study, male participants but not female participants were more often married than non-participants ([@bib73]).

### 3.4.9. Age {#sec3.4.9}

In the FHS, men under 45 responded less often than women under 45 ([@bib24]). GAZEL studied the interaction of age, sex/gender and employment grade ([@bib23]). Among men, response decreased with increasing age among unskilled workers only. On the other hand, response decreased with increasing age among female managers ([@bib23]). In VIP, the youngest age-group was less represented among both women and men ([@bib79]). EPIC Germany stratified response of age-groups by sex/gender and place of residence and found that response among old men and women was higher in Potsdam compared to Heidelberg ([@bib8]). Stratifying response of age-groups by sex/gender showed that response was lowest among males in the youngest age-groups and females in the oldest age-groups in HNR and SHIP ([@bib46]; [@bib73]). In KORA, young and old men responded less frequently to a non-responder survey compared to women of the same age-group ([@bib33]). The proportion of males of any age-group was reported to be close to the proportions in the target population in Lifelines, while females of younger age-groups were overrepresented ([@bib38]). Similarly, men of the youngest age-group in CaG showed the lowest response proportion ([@bib2]). LidA reported that representativeness of two birth cohorts did not differ between females and males ([@bib29]). In Tromsø 6, response proportions among women and men were similar across all age-groups with an exception of the oldest age-group. People over 80 years of age in Tromsø 6 showed a lower response among both women and men ([@bib17]).

### 3.4.10. Dis/ability {#sec3.4.10}

Characteristics related to dis/ability were not reported in any study.

### 3.4.11. Sexuality {#sec3.4.11}

Characteristics related to sexuality were not reported in any study.

4. Discussion {#sec4}
=============

Methods to investigate representativeness of the study population differed between the included cohort studies. Descriptive statistics of the study population and response proportions were most common when describing representativeness. Studies regularly reported sex/gender, age and information on place of residence of the study population which is in line with findings from clinical trials ([@bib12]; [@bib25]). Other groups of the PROGRESS plus framework were reported inconsistently. Social characteristics were rarely stratified for each other. If stratification was applied, characteristics were frequently stratified by sex/gender and age. We noted some differential patterns of representativeness after stratifying by a variable of a different PROGRESS plus group. For example, response proportions among women and men were frequently reported to be differential by age. Men responded less often than women in younger age-groups, while differences in response between women and men were less pronounced in older age-groups. Finally, GAZEL reported interaction of employment grade and sex/gender with year of birth, length of employment, educational level and number of children when studying risk factors of non-response ([@bib23]).

The identified information of the included cohort studies gives an overview of the practice of reporting on representativeness. Nevertheless, our results summarize the practice of describing representativeness in methodological publications only. We might have missed information on representativeness, if it was published in an article about a specific research question. Additionally, the variability of the identified information on representativeness might be due to heterogeneous study designs. CONOR and EPIC, for example, are large consortia of cohort studies. Results on representativeness of single study centers of CONOR and EPIC are available but were not displayed in the description of the overall project. Add Health, on the other hand, used complex techniques to adjust for non-response while no description of social characteristics of the study population was found in methodological publications ([@bib28]; [@bib36]). Furthermore, some characteristics of PROGRESS plus could not be collected due to legal barriers in some studies. For example, the collection of data on ethnicity or religion was banned in several European countries until recently ([@bib70]). Our findings are not representative of the entire body of epidemiological studies, because the selection of studies was subjective. Moreover, the included studies have been conducted in different time periods and regions. Hence, our results should be understood as a sketch of epidemiological practice across different time periods and social contexts.

Another important aspect that might explain the heterogeneous descriptions of representativeness is that some included studies specifically aimed at obtaining a representative sample, while others focused on low attrition in order to estimate internally valid measures of effect ([@bib13]). MORGEN, HNR, CaG or Tromsø 6, for example, explicitly aimed at recruiting representative study populations in order to be able to estimate valid measures of disease burden in the target population ([@bib2]; [@bib17]; [@bib73]; [@bib75]). For example, MESA, the UK Biobank or CKB were not designed to include a representative study population and instead aimed at studying causal effects ([@bib11]; [@bib22]; [@bib59]). Internally valid effect estimates from unrepresentative cohort studies may be generalizable if effect measure modification of the relationship under study is absent ([@bib68]). It is important to keep in mind that cohort studies can be designed for these different purposes.

Past analyses of representativeness of social locations are limited, because mostly descriptions of few independent social characteristics were used to characterize the study population and the theoretical rationale of these descriptions has not been stated explicitly. Lisa Bowleg, who was among the first to introduce intersectionality to public health theory, research and policy, illustrated in 2012 that epidemiological or clinical research need to consider tenets of intersectionality when dealing with studies\' representation of complex societies ([@bib10]). She noted that the policy of the NIH to include "women and minorities" in all NIH-funded studies was problematic due to the assumed mutual exclusivity of both populations and the multidimensionality and inaccuracy of the term "minorities" ([@bib10]; ; [@bib54]). In the following we present further arguments why intersectionality can advance the practice of investigating representativeness in epidemiological and clinical research.

First, intersectionality posits that intersections of social characteristics constitute unique social locations that cannot be adequately described when analyzing each dimension independently ([@bib10]; [@bib26]). By making intersectional strata visible through analyses of combinations of multiple social characteristics, complexity of social reality might be represented more adequately ([@bib16]; [@bib48]). Second, intersectionality, calls attention to combinations of characteristics indicating privilege with characteristics indicating disadvantage such as highly educated persons with migration background ([@bib26]). This perspective is hidden when analyzing single characteristics and shows that almost all strata are combinations of privileged and oppressed categories. By decentering the focus from single characteristics, intersectionality might furthermore contribute to avoid the reinforcement of stereotypes ([@bib16]). Consequently, an intersectional perspective highlights that systems of social power are mutually dependent and inseparably related to one another ([@bib16]).

This notion of interrelatedness has not been considered in recently developed frameworks that aim to capture dimensions of social location. For example, PROGRESS plus compiled an overview of meaningful characteristics for the description of study populations that moves beyond analyses of commonly studied characteristics such as age, socioeconomic position or sex/gender ([@bib58]). However, the mutual dependence of these dimensions is not considered. Therefore, frameworks such as PROGRESS plus need to be informed by intersectionality and extended by incorporating perspectives that highlight mutual dependence of all considered categories ([@bib10]; [@bib26]).

In addition to characteristics investigated in this study, health states like BMI, mental health or HIV status might be considered as further important characteristics in an intersectional approach to representativeness because health might be both a cause of power inequality and a predictor of study participation ([@bib56]; [@bib63]; [@bib74]; [@bib80]). In epidemiological studies, descriptions of health-related characteristics should be part of comprehensive investigations of selection bias ([@bib31]).

Nonetheless, some caveats should be kept in mind when applying an intersectional approach ([@bib10]; [@bib16]; [@bib48]). To start with, combinations of essentialist characteristics are still used and the risk remains that this perspective further emphasizes and shapes difference ([@bib48]). Moreover, relevant intersections should be identified anew for each social and historical context in which a study is conducted ([@bib16]). The use of standard sets of intersections such as a universal application of all PROGRESS plus groups is not recommended ([@bib16]). Finally, intersectionality aims at investigating the socio-structural level as well as social processes ([@bib10]), which we neglected to a large part by focusing on social location as an individual characteristic.

An application of intersectionality theory requires the use of novel statistical approaches to analyze multiple interactions. Statistical challenges arise when stratifying a population by several variables because numbers of observations within each stratum decrease geometrically ([@bib43]). This limitation can be addressed by applications of established and novel statistical methods that aim to operationalize intersectionality. In past studies on intersectional research questions, combinations of two or three variables have been investigated by stratification or by interaction analyses of two to three variables ([@bib49]). Innovative methods that were used in past studies are classification and regression tree analysis or synergy indices ([@bib49]). Recently developed methods include intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA), which can handle small numbers of observations among intersectional strata if the overall sample size is large ([@bib3];[@bib20]; [@bib30]; [@bib51]). Applications of intersectional MAIHDA to non-responder data, for example, might yield new insights into representativeness across intersectional strata in large population-based studies.

Extended analyses of representativeness are probably most relevant in descriptive epidemiology ([@bib68]). If differential patterns of response are discovered across intersectional strata, findings might be used to refine calculation of weights to adjust for non-response ([@bib7]; [@bib37]). Intersectionality might reveal an underrepresentation of multiply marginalised groups, which needs to be considered when interpreting research results. This knowledge is crucial, as marginalised groups have been historically excluded from research and often suffer from a high burden of disease ([@bib45]). Therefore, findings might be used for the development of targeted recruitment strategies. However, specifically targeting vulnerable social groups might reinforce social separation and should only be considered after careful evaluation ([@bib18]).

Knowledge on differential response patterns might also be useful to evaluate risk for selection bias of measures of effect and population impact. Large longitudinal studies with low representativeness might be at higher risk to yield estimates of effect that might not be generalizable, especially when effect measure modification is present ([@bib72]). It has been shown that measures of effect might be biased if both effect measure modification and differential response according to the modifying factor are present ([@bib35]). Effect measure modification might be anticipated for example when investigating research questions in social epidemiology ([@bib60]; [@bib68]). While drawing generalizable conclusions on causal relationships is possible in studies with low representativeness, measures of population impact need to be estimated in representative studies ([@bib68]). Applying an intersectional analysis of representativeness could add an additional layer of certainty when aiming to draw generalizable conclusions on causal effects and population impact of risk factors.

Finally, epidemiology has gradually moved past estimating population averages towards mapping heterogeneity of disease burden in a population as well as studying heterogeneity of effects ([@bib50], [@bib51]). MAIHDA, for example, aids to map heterogeneity of disease frequencies among intersectional strata of a population ([@bib20]; [@bib62]). If epidemiological studies, on the other hand, aim at estimating effect heterogeneity across population subgroups, study designs might need to adapt. It has been suggested, for example, to study several homogeneous population strata that are heterogeneous in relation to each other rather than representative samples of the general population to estimate effect heterogeneity ([@bib52]).

In conclusion, applying the concept of intersectionality might approximate social complexity when investigating representativeness by taking account of the multiplicity of social location. An intensified integration of sociological concepts might advance our understanding of representativeness and current epidemiological practice.
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[^1]: Method of describing representativeness of the study population: A) descriptive statistics of the study population; B) response proportions (according to age or sex/gender); C) non-responder survey; D) comparison to the sampling frame, survey or census data (characteristics other than age and sex/gender).

[^2]: Cooperation proportion.

[^3]: Proportion of all registered births during study period.

[^4]: Estimated in in-house survey.
